@WashburneMaggie maybe pretreatment with a safer blood thinner than #warfarin and #heparin. Here it shows Latin Americans have a 1.55 increased risk for bleeding and intracerebral stroke https://t.co/BMG5bR3Lc2
Edoxaban Versus Warfarin in Latin American Patients With Atrial Fibrillation: The ENGAGE AF-TIMI 48 Trial. https://t.co/1GCbt2gJTq
RT @drdargaray: In LatinAmerican patients with atrial fibrillation, the risk of death & intracranial hemorrhage were higher when compared w…
RT @drdargaray: In LatinAmerican patients with atrial fibrillation, the risk of death & intracranial hemorrhage were higher when compared w…
RT @drdargaray: In LatinAmerican patients with atrial fibrillation, the risk of death & intracranial hemorrhage were higher when compared w…
In LatinAmerican patients with atrial fibrillation, the risk of death & intracranial hemorrhage were higher when compared with non-LatAm; Edoxaban reduced MACE and hemorrhagic stroke in LatAm patients @cardiodata @carlos_sierra @YoungACCA @AntonioJorda
RT @JACCJournals: Is edoxoban better than warfarin in Latin American #AFib patients? https://t.co/ZfFDnSzTYs #JACC #cardiotwitter @rgiuglia…
RT @JACCJournals: Is edoxoban better than warfarin in Latin American #AFib patients? https://t.co/ZfFDnSzTYs #JACC #cardiotwitter @rgiuglia…
RT @JACCJournals: Is edoxoban better than warfarin in Latin American #AFib patients? https://t.co/ZfFDnSzTYs #JACC #cardiotwitter @rgiuglia…
RT @JACCJournals: Is edoxoban better than warfarin in Latin American #AFib patients? https://t.co/ZfFDnSzTYs #JACC #cardiotwitter @rgiuglia…
RT @JACCJournals: Is edoxoban better than warfarin in Latin American #AFib patients? https://t.co/ZfFDnSzTYs #JACC #cardiotwitter @rgiuglia…
RT @JORARTU: Edoxaban Versus Warfarin in Latin American Patients With Atrial Fibrillation: The ENGAGE AF-TIMI 48 Trial https://t.co/IUEPrSk…
RT @JACCJournals: Is edoxoban better than warfarin in Latin American #AFib patients? https://t.co/ZfFDnSzTYs #JACC #cardiotwitter @rgiuglia…
RT @JACCJournals: Is edoxoban better than warfarin in Latin American #AFib patients? https://t.co/ZfFDnSzTYs #JACC #cardiotwitter @rgiuglia…
Edoxaban Versus Warfarin in Latin American Patients With Atrial Fibrillation: The ENGAGE AF-TIMI 48 Trial https://t.co/IUEPrSkuIm
RT @JACCJournals: Is edoxoban better than warfarin in Latin American #AFib patients? https://t.co/ZfFDnSzTYs #JACC #cardiotwitter @rgiuglia…
RT @JACCJournals: Is edoxoban better than warfarin in Latin American #AFib patients? https://t.co/ZfFDnSzTYs #JACC #cardiotwitter @rgiuglia…
RT @bernardowise: Is edoxoban better than warfarin in Latin American #AFib patients? #LatAm #CardioTwitter https://t.co/FuNUKO1Fcz
Is edoxoban better than warfarin in Latin American #AFib patients? #LatAm #CardioTwitter https://t.co/FuNUKO1Fcz
RT @JACCJournals: Is edoxoban better than warfarin in Latin American #AFib patients? https://t.co/ZfFDnSzTYs #JACC #cardiotwitter @rgiuglia…
RT @JACCJournals: Is edoxoban better than warfarin in Latin American #AFib patients? https://t.co/ZfFDnSzTYs #JACC #cardiotwitter @rgiuglia…
Is edoxoban better than warfarin in Latin American #AFib patients? https://t.co/ZfFDnSzTYs #JACC #cardiotwitter @rgiugliano @BrighamWomens https://t.co/FCBWVWOFBD